LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
1.7783
 27.84 770.25 1493 2833 0.5268 0.4221
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 27.84 770.25 1927 2833 0.6800 0.6289
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 30.06 770.25 1592 3106 0.5125 0.4346
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 30.06 770.25 2041 3106 0.6571 0.6232
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 32.28 770.25 1682 3392 0.4957 0.4407
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 32.28 770.25 2166 3392 0.6384 0.6215
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 34.50 770.25 1738 3712 0.4682 0.4314
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 34.50 770.25 2272 3712 0.6121 0.6109
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 36.73 770.25 1815 4086 0.4442 0.4277
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 36.73 770.25 2390 4086 0.5849 0.6006
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 38.95 770.25 1880 4543 0.4137 0.4169
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 38.95 770.25 2460 4543 0.5414 0.5738
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 41.17 770.25 1964 5010 0.3920 0.4141
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 41.17 770.25 2584 5010 0.5157 0.5652
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 43.39 770.25 2066 5404 0.3823 0.4205
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 43.39 770.25 2736 5404 0.5063 0.5698
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 45.61 770.25 2159 5813 0.3714 0.4240
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 45.61 770.25 2879 5813 0.4953 0.5717
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 47.83 770.25 2294 6223 0.3686 0.4363
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 47.83 770.25 3019 6223 0.4851 0.5733
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 50.05 770.25 2391 6629 0.3607 0.4402
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 50.05 770.25 3190 6629 0.4812 0.5803
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 52.27 770.25 2481 7058 0.3515 0.4419
MN20160304_L02
F13
MCF 10A-H2B-mCherry Dasatinib
1.7783
 52.27 770.25 3339 7058 0.4730 0.5824
MN20160304_L02
L16
MCF 10A-H2B-mCherry Dasatinib
1.7783
 54.49 770.25 2596 7555 0.3436 0.4461
MN20160304_L02
F13